Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

In agreement with a previous meta-analysis, that was conducted on DPP-4 inhibitors including four studies on alogliptin, [27] this meta-analysis has demonstrated a significant reduction of HbA1c ...

For patients with heart failure (HF), a greater focus on medication management may be needed in order to mitigate HF exacerbations caused by certain ...

List of 117 Public Health journals with full access to their articles that can be viewed and accessed without any cost.

The Amsler grid is a good test for people with Macular Degeneration. The Amsler grid tests the condition of the center of the retina or "macula" ...

Alogliptin helps stimulate the release of insulin after a meal, which leads to better blood sugar control.” Mary Parks, M.D., director of the Division of Metabolism and Endocrinology Products in ...

DPP-4 inhibitors improve your blood sugar without making it drop too low alogliptin (Nesina), linagliptin (Tradjenta), saxagliptin (Onglyza), and sitagliptin (Januvia) glucagon-like peptides ...

Along with lifestyle changes, metformin can help you get your blood sugar, also called blood glucose, under control. If your blood sugar is not controlled, metformin may not be working for you, and ...

Inhibitors of the enzyme DPP-4, such as sitagliptin, lower blood sugar while being safe and tolerable. Vildagliptin and alogliptin were well tolerated and showed excellent safety profiles. The drugs ...